Response to CMA provisional decision announcement

Summary by AI BETAClose X

CVS Group plc has responded to the Competition and Markets Authority's (CMA) provisional decision announcement regarding the veterinary market investigation. CVS welcomes the certainty and will respond to the decision and proposed remedies in writing, with a hearing scheduled for December 2025, anticipating the final decision in March 2026. The initial 28 remedies proposed in May 2025 have been refined to 21, with no new remedies introduced. CVS will collaborate with the CMA to refine the remedies package, ensuring it is workable, deliverable, and implementable, including joint branding and standardized price lists. The Board expects the Group to trade in line with market expectations.

Disclaimer*

Companies

CVS Group (CVSG)
UK 100

Latest directors dealings